Nonetheless, our study offers valuable insights into the potential benefits of using Cystatin C-based eGFR in diagnosing and managing renal disease in HIV-positive individuals, particularly highlighting the high precision of Cystatin C-based eGFR formulas. This evidence concerns the gene CST3 and kidney disorder.